List of Tables
    Table 1. Bivalirudin CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Bivalirudin Market Trends
    Table 3. Bivalirudin Market Drivers
    Table 4. Bivalirudin Market Challenges
    Table 5. Bivalirudin Market Restraints
    Table 6. Global Bivalirudin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Bivalirudin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Bivalirudin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Bivalirudin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Bivalirudin Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Bivalirudin Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Bivalirudin Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Bivalirudin Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Bivalirudin Sales Share by Manufacturer, 2017-2022
    Table 15. Global Bivalirudin Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Bivalirudin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Bivalirudin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bivalirudin as of 2021)
    Table 18. Top Players of Bivalirudin in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Bivalirudin Product Type
    Table 20. Date of International Manufacturers Enter into Bivalirudin Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Bivalirudin Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Bivalirudin Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Bivalirudin Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Bivalirudin Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Bivalirudin Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Bivalirudin Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Bivalirudin Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Bivalirudin Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Bivalirudin Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Bivalirudin Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Bivalirudin Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Bivalirudin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Bivalirudin Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Bivalirudin Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Bivalirudin Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Bivalirudin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Bivalirudin Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Bivalirudin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Bivalirudin Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Bivalirudin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bachem Corporation Information
    Table 43. Bachem Description and Business Overview
    Table 44. Bachem Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. Bachem Bivalirudin Product
    Table 46. Bachem Recent Development
    Table 47. Teva Pharmaceutical Industries Corporation Information
    Table 48. Teva Pharmaceutical Industries Description and Business Overview
    Table 49. Teva Pharmaceutical Industries Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. Teva Pharmaceutical Industries Product
    Table 51. Teva Pharmaceutical Industries Recent Development
    Table 52. Ambiopharm Corporation Information
    Table 53. Ambiopharm Description and Business Overview
    Table 54. Ambiopharm Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. Ambiopharm Product
    Table 56. Ambiopharm Recent Development
    Table 57. ChemWerth Corporation Information
    Table 58. ChemWerth Description and Business Overview
    Table 59. ChemWerth Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. ChemWerth Product
    Table 61. ChemWerth Recent Development
    Table 62. ScinoPharm Corporation Information
    Table 63. ScinoPharm Description and Business Overview
    Table 64. ScinoPharm Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. ScinoPharm Product
    Table 66. ScinoPharm Recent Development
    Table 67. Salubris Corporation Information
    Table 68. Salubris Description and Business Overview
    Table 69. Salubris Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Salubris Product
    Table 71. Salubris Recent Development
    Table 72. Suzhou No.4 Pharmaceutical Factory Corporation Information
    Table 73. Suzhou No.4 Pharmaceutical Factory Description and Business Overview
    Table 74. Suzhou No.4 Pharmaceutical Factory Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. Suzhou No.4 Pharmaceutical Factory Product
    Table 76. Suzhou No.4 Pharmaceutical Factory Recent Development
    Table 77. SOHO-YIMING Pharmaceuticals Corporation Information
    Table 78. SOHO-YIMING Pharmaceuticals Description and Business Overview
    Table 79. SOHO-YIMING Pharmaceuticals Bivalirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 80. SOHO-YIMING Pharmaceuticals Product
    Table 81. SOHO-YIMING Pharmaceuticals Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Bivalirudin Customers List
    Table 85. Bivalirudin Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bivalirudin Product Picture
    Figure 2. Global Bivalirudin Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Bivalirudin Market Size 2017-2028 (US$ Million)
    Figure 4. Global Bivalirudin Sales 2017-2028 (MT)
    Figure 5. United States Bivalirudin Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Bivalirudin Market Size 2017-2028 (US$ Million)
    Figure 7. United States Bivalirudin Sales 2017-2028 (MT)
    Figure 8. United States Bivalirudin Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Bivalirudin Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Bivalirudin Report Years Considered
    Figure 11. Product Picture of ≥ 99.0%
    Figure 12. Product Picture of ＜ 99.0%
    Figure 13. Global Bivalirudin Market Share by Type in 2022 & 2028
    Figure 14. Global Bivalirudin Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Bivalirudin Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Bivalirudin Sales by Type (2017-2028) & (MT)
    Figure 17. Global Bivalirudin Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Bivalirudin Price by Type (2017-2028) & (USD/Kg)
    Figure 19. United States Bivalirudin Market Share by Type in 2022 & 2028
    Figure 20. United States Bivalirudin Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Bivalirudin Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Bivalirudin Sales by Type (2017-2028) & (MT)
    Figure 23. United States Bivalirudin Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Bivalirudin Price by Type (2017-2028) & (USD/Kg)
    Figure 25. Product Picture of Thrombin Inhibitor
    Figure 26. Product Picture of Application 2
    Figure 27. Global Bivalirudin Market Share by Application in 2022 & 2028
    Figure 28. Global Bivalirudin Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Bivalirudin Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Bivalirudin Sales by Application (2017-2028) & (MT)
    Figure 31. Global Bivalirudin Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Bivalirudin Price by Application (2017-2028) & (USD/Kg)
    Figure 33. United States Bivalirudin Market Share by Application in 2022 & 2028
    Figure 34. United States Bivalirudin Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Bivalirudin Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Bivalirudin Sales by Application (2017-2028) & (MT)
    Figure 37. United States Bivalirudin Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Bivalirudin Price by Application (2017-2028) & (USD/Kg)
    Figure 39. North America Bivalirudin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 40. North America Bivalirudin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Bivalirudin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 44. Europe Bivalirudin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Bivalirudin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 51. Asia-Pacific Bivalirudin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Bivalirudin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 63. Latin America Bivalirudin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Bivalirudin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 68. Middle East & Africa Bivalirudin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Bivalirudin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Bivalirudin Value Chain
    Figure 73. Bivalirudin Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed